Pharmaceutical Advertising 2025 | Global Practice Guides

<!DOCTYPE html> <html lang="en-gb"> <head>  <script type="text/javascript" src=https://cdn.cookielaw.org/consent/1c35042a-55e8-436f-9149-6484f146df26/OtAutoBlock.js ></script> <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script=1c35042a-55e8-436f-9149-6484f146df26></script> <script src="/bundles/sharedLayout?v=8-Hr7uXaaQtmCYIu_vpjM4HdduzmFQ9vaR_LYex7zTQ1"></script> <script type="text/javascript"> function OptanonWrapper() { } </script>  <meta charset="utf-8" /> <meta name="viewport" content="width=device-width, initial-scale=1.0"> <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" /> <title> Pharmaceutical Advertising 2025 | Global Practice Guides | Chambers and Partners</title> <meta description="Chambers Global Practice Guides, Chambers Practice Guides, Global Practice Guides, Country Practice Guides, Practice Guides" /> <link rel="stylesheet" type="text/css" href="//maxcdn.bootstrapcdn.com/font-awesome/4.4.0/css/font-awesome.min.css"> <link rel="stylesheet" type="text/css" href="//fonts.googleapis.com/css?family=Work+Sans:400,300,700"> <script type="text/javascript" src="https://secure.leadforensics.com/js/142862.js"></script> <noscript><img alt="" src="https://secure.leadforensics.com/142862.png" style="display: none;" /></noscript> <link href="/bundles/css?v=duJHNN7GDR7hvYlntLUfCgKeX0AjRfSMXNb8c98ziJw1" rel="stylesheet"/> <script src="/bundles/modernizr?v=wBEWDufH_8Md-Pbioxomt90vm6tJN2Pyy9u9zHtWsPo1"></script>  <script src="https://ajax.googleapis.com/ajax/libs/angularjs/1.4.5/angular.min.js"></script> <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.12.0/jquery.min.js"></script> <script src="/bundles/lodash?v=i5x2VZFAGflxq7l14LtgcO7YY2aW2oTtk8V9_DaSMhs1"></script> <script src="/bundles/tabdrop?v=kh8bpdG0nL6xAgxv-dHlCknJogMZA6oVQOehGLkZGs01"></script>  <script async src="https://www.googletagmanager.com/gtag/js?id=UA-2506633-16"></script> <script> window.dataLayer = window.dataLayer || []; function gtag() { dataLayer.push(arguments); } gtag('js', new Date()); gtag('config', 'UA-2506633-16'); </script>  <script> var gtmAuth = 'ONaGQDepZvyrlC3qm_-xAA' ? '&gtm_auth=ONaGQDepZvyrlC3qm_-xAA' : ''; var gtmPreview = 'env-3' ? '&gtm_preview=env-3' : ''; (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl + gtmAuth + gtmPreview + '&gtm_cookies_win=x'; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-5XQNXQW'); </script>  <script type="text/javascript"> var api = {}; api.apiUrl = 'https://practiceguides.chambers.com/'; var appInsights = window.appInsights || function(config) { function r(config) { t[config] = function() { var i = arguments; t.queue.push(function() { t[config].apply(t, i) }) } } var t = { config: config }, u = document, e = window, o = "script", s = u.createElement(o), i, f; for (s.src = config.url || "//az416426.vo.msecnd.net/scripts/a/ai.0.js", u.getElementsByTagName(o)[0].parentNode.appendChild(s), t.cookie = u.cookie, t.queue = [], i = ["Event", "Exception", "Metric", "PageView", "Trace"]; i.length;) r("track" + i.pop()); return r("setAuthenticatedUserContext"), r("clearAuthenticatedUserContext"), config.disableExceptionTracking || (i = "onerror", r("_" + i), f = e[i], e[i] = function(config, r, u, e, o) { var s = f && f(config, r, u, e, o); return s !== !0 && t["_" + i](config, r, u, e, o), s }), t }({ instrumentationKey: '7bd819af-4043-493e-9411-98089bd04f13' }); window.appInsights = appInsights; appInsights.trackPageView(); </script> </head> <body class="country">  <noscript> <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5XQNXQW&gtm_auth=ONaGQDepZvyrlC3qm_-xAA&gtm_preview=env-3&gtm_cookies_win=x" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript>  <div class="wrapper"> <nav class="nav"> <div class="container"> <a href="/home" class="header-top-logo"></a> </div> <div class="nav__top"> <div class="container"> <div class="pull-right"> <a href="https://chambers.com" title="go to Chambers and Partners" target="_blank"> <span class="jump-link hidden-sm hidden-xs">Chambers and Partners website</span> <i class="mdi mdi-open-in-new"></i> </a> <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false" aria-controls="navbar"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar"></span> <span class="icon-bar"></span> <span class="icon-bar"></span> </button> </div> </div> </div> <div class="nav__btm"> <div class="container"> <div id="navbar" class="navbar-collapse collapse -remove-padding -remove-margin"> <ul class="navbar-nav js-navmenu"> <li><a href="/home">HOME</a></li> <li><a href="/practicearea">PRACTICE GUIDES</a></li> <li><a href="/jurisdiction">JURISDICTIONS</a></li> <li><a href="/author" class="second-menu-line menu-contributions">CONTRIBUTORS</a></li> <li><a href="/about" class="second-menu-line menu-about">ABOUT</a></li> <li><a href="/contact" class="second-menu-line menu-contact">CONTACT</a></li> <li> <a class="hidden-lg hidden-md hidden-sm visible-xs" href="https://chambers.com" target="_blank"> Chambers and Partners website </a> </li> </ul> </div> </div> </div> </nav> <div class="container" id="body-content"> <div class="row home-page-first-row"> <section class="col-xs-12"> <div data-ng-app="MainModule" ng-cloak> <div data-ng-controller="CountryCtrl" data-ng-init="listOfCountries=[{"Id":15579,"Description":"Belgium","LocationDescription":"Belgium","LocationId":32,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15580,"Description":"Canada","LocationDescription":"Canada","LocationId":50,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15581,"Description":"China","LocationDescription":"China","LocationId":60,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":null,"IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15582,"Description":"Denmark","LocationDescription":"Denmark","LocationId":70,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15583,"Description":"France","LocationDescription":"France","LocationId":86,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":null,"IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15584,"Description":"Japan","LocationDescription":"","LocationId":null,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15585,"Description":"Mexico","LocationDescription":"Mexico","LocationId":144,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15586,"Description":"Poland","LocationDescription":"Poland","LocationId":173,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15562,"Description":"Portugal","LocationDescription":"Portugal","LocationId":174,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15587,"Description":"Spain","LocationDescription":"Spain","LocationId":194,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15588,"Description":"Sweden","LocationDescription":"Sweden","LocationId":203,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15589,"Description":"Switzerland","LocationDescription":"Switzerland","LocationId":204,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null},{"Id":null,"Title":"Trends and Developments","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null},{"Id":15590,"Description":"USA","LocationDescription":"USA","LocationId":225,"RankingGuideLocationId":null,"Editorials":null,"TopicsList":[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":null}],"Authors":null,"IsSelected":false,"BusinessCards":null,"DateModify":null,"DatePublish":null}];listOfTopics=[{"Id":null,"Title":"Law and Practice","IsSelected":false,"DisplayOrder":0,"QuestionGroups":[{"Id":24302,"BookId":962,"ParentId":null,"Description":"1. Pharmaceutical Advertising: Regulatory Framework","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[{"Id":24314,"BookId":962,"ParentId":24302,"Description":"1.1 Laws and Self-Regulatory Codes Concerning the Advertisement and Promotion of Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24315,"BookId":962,"ParentId":24302,"Description":"1.2 Application and Influence of Self-Regulatory Codes on the Advertisement and Promotion of Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24303,"BookId":962,"ParentId":null,"Description":"2. Scope of Advertising and General Principles","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[{"Id":24316,"BookId":962,"ParentId":24303,"Description":"2.1 Definition of Advertising","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24317,"BookId":962,"ParentId":24303,"Description":"2.2 Information or Advertising: Disease Awareness Campaigns and Other Patient-Facing Information","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24318,"BookId":962,"ParentId":24303,"Description":"2.3 Restrictions on Press Releases Regarding Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24319,"BookId":962,"ParentId":24303,"Description":"2.4 Comparative Advertising for Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24304,"BookId":962,"ParentId":null,"Description":"3. Advertising of Unauthorised Medicines or Unauthorised Indications","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[{"Id":24320,"BookId":962,"ParentId":24304,"Description":"3.1 Restrictions on the Provision of Information Concerning Unauthorised Medicines or Indications","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24321,"BookId":962,"ParentId":24304,"Description":"3.2 Provision of Information During a Scientific Conference","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24322,"BookId":962,"ParentId":24304,"Description":"3.3 Provision of Information to Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24323,"BookId":962,"ParentId":24304,"Description":"3.4 Provision of Information to Healthcare Institutions","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24324,"BookId":962,"ParentId":24304,"Description":"3.5 Information About Early Access or Compassionate Use Programmes","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24305,"BookId":962,"ParentId":null,"Description":"4. Advertising Pharmaceuticals to the General Public","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[{"Id":24325,"BookId":962,"ParentId":24305,"Description":"4.1 Main Restrictions on Advertising Pharmaceuticals to the General Public","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24326,"BookId":962,"ParentId":24305,"Description":"4.2 Information Contained in Pharmaceutical Advertising to the General Public","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24327,"BookId":962,"ParentId":24305,"Description":"4.3 Restrictions on Interactions Between Patients or Patient Organisations and Industry","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24306,"BookId":962,"ParentId":null,"Description":"5. Advertising to Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[{"Id":24328,"BookId":962,"ParentId":24306,"Description":"5.1 Restrictions on Information Contained in Advertising Directed at Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24329,"BookId":962,"ParentId":24306,"Description":"5.2 Reference to Data Not Included in the Summary of Product Characteristics","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24330,"BookId":962,"ParentId":24306,"Description":"5.3 Advertising of Combination Products ","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24331,"BookId":962,"ParentId":24306,"Description":"5.4 Advertising of Companion Diagnostics","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24332,"BookId":962,"ParentId":24306,"Description":"5.5 Restrictions on Reprints of Journal Articles for Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24333,"BookId":962,"ParentId":24306,"Description":"5.6 Medical Science Liaisons","IsNumbered":true,"IsSelected":false,"DisplayOrder":6,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24307,"BookId":962,"ParentId":null,"Description":"6. Vetting Requirements and Internal Verification Compliance","IsNumbered":true,"IsSelected":false,"DisplayOrder":6,"ChildrenQuestionGroups":[{"Id":24334,"BookId":962,"ParentId":24307,"Description":"6.1 Requirements for Prior Notification/Authorisation of Advertising Materials ","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24335,"BookId":962,"ParentId":24307,"Description":"6.2 Compliance With Rules Concerning Medicinal Product Advertising","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24308,"BookId":962,"ParentId":null,"Description":"7. Advertising of Medicinal Products on the Internet and Through Digital and Electronic Platforms Including Social Media","IsNumbered":true,"IsSelected":false,"DisplayOrder":7,"ChildrenQuestionGroups":[{"Id":24336,"BookId":962,"ParentId":24308,"Description":"7.1 The Advertisement of Medicinal Products on the Internet","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24337,"BookId":962,"ParentId":24308,"Description":"7.2 Restrictions on Access to Websites Containing Material Intended for Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24338,"BookId":962,"ParentId":24308,"Description":"7.3 Provision of Disease Awareness Information to the General Public Online","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24339,"BookId":962,"ParentId":24308,"Description":"7.4 Virtual Scientific Meetings","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24340,"BookId":962,"ParentId":24308,"Description":"7.5 Use of Social Media","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24309,"BookId":962,"ParentId":null,"Description":"8. Pharmaceutical Advertising: Inducement/Anti-Bribery","IsNumbered":true,"IsSelected":false,"DisplayOrder":8,"ChildrenQuestionGroups":[{"Id":24341,"BookId":962,"ParentId":24309,"Description":"8.1 Anti-Bribery Legislation Applicable to Interactions Between Pharmaceutical Companies and Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24342,"BookId":962,"ParentId":24309,"Description":"8.2 Controls on the Provision by Pharmaceutical Companies of Benefits and/or Inducements to Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24310,"BookId":962,"ParentId":null,"Description":"9. Gifts, Hospitality, Congresses and Related Payments","IsNumbered":true,"IsSelected":false,"DisplayOrder":9,"ChildrenQuestionGroups":[{"Id":24343,"BookId":962,"ParentId":24310,"Description":"9.1 Gifts to Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24344,"BookId":962,"ParentId":24310,"Description":"9.2 The Provision of Samples of Medicinal Products to Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24345,"BookId":962,"ParentId":24310,"Description":"9.3 Sponsorship of Scientific Meetings","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24346,"BookId":962,"ParentId":24310,"Description":"9.4 Sponsorship of Cultural, Sports or Other Non-Scientific Events","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24347,"BookId":962,"ParentId":24310,"Description":"9.5 Grants or Donations to Healthcare Professionals or Healthcare Institutions","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24348,"BookId":962,"ParentId":24310,"Description":"9.6 Restrictions on Rebates or Discounts to Healthcare Professionals or Healthcare Institutions","IsNumbered":true,"IsSelected":false,"DisplayOrder":6,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24349,"BookId":962,"ParentId":24310,"Description":"9.7 Payment for Services Provided by Healthcare Professionals","IsNumbered":true,"IsSelected":false,"DisplayOrder":7,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24350,"BookId":962,"ParentId":24310,"Description":"9.8 Prior Authorisations or Notifications for Activities Between Pharmaceutical Companies, Healthcare Professionals and Healthcare Organisations","IsNumbered":true,"IsSelected":false,"DisplayOrder":8,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24311,"BookId":962,"ParentId":null,"Description":"10. Pharmaceutical Companies: Transparency","IsNumbered":true,"IsSelected":false,"DisplayOrder":10,"ChildrenQuestionGroups":[{"Id":24351,"BookId":962,"ParentId":24311,"Description":"10.1 Requirement for Pharmaceutical Companies to Disclose Details of Transfers of Value","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24352,"BookId":962,"ParentId":24311,"Description":"10.2 Foreign Companies and Companies That Do Not Yet Have Products on the Market","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24312,"BookId":962,"ParentId":null,"Description":"11. Pharmaceutical Advertising: Enforcement","IsNumbered":true,"IsSelected":false,"DisplayOrder":11,"ChildrenQuestionGroups":[{"Id":24353,"BookId":962,"ParentId":24312,"Description":"11.1 Pharmaceutical Advertising: Enforcement Bodies","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24354,"BookId":962,"ParentId":24312,"Description":"11.2 Initiating Proceedings for Pharmaceutical Advertising Infringements","IsNumbered":true,"IsSelected":false,"DisplayOrder":2,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24355,"BookId":962,"ParentId":24312,"Description":"11.3 Sanctions for Violating Pharmaceutical Advertising Rules and Rules on Inducements to Prescribe","IsNumbered":true,"IsSelected":false,"DisplayOrder":3,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24356,"BookId":962,"ParentId":24312,"Description":"11.4 Relationship Between Regulatory Authorities and Courts","IsNumbered":true,"IsSelected":false,"DisplayOrder":4,"ChildrenQuestionGroups":[],"Answer":null},{"Id":24357,"BookId":962,"ParentId":24312,"Description":"11.5 Recent Enforcement Trends in Relation to Pharmaceutical Advertising","IsNumbered":true,"IsSelected":false,"DisplayOrder":5,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null},{"Id":24313,"BookId":962,"ParentId":null,"Description":"12. Veterinary Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":12,"ChildrenQuestionGroups":[{"Id":24358,"BookId":962,"ParentId":24313,"Description":"12.1 Advertising Veterinary Medicines","IsNumbered":true,"IsSelected":false,"DisplayOrder":1,"ChildrenQuestionGroups":[],"Answer":null}],"Answer":null}]}];"> <div class="col-md-8"> <div class="row"> <div class="col-sm-3 col-md-4 col-xs-12"> <img src="https://chambersandpartners.azureedge.net/practiceguides/pharmaceutical-advertising-2025-lg.jpg" class="img-responsive guide-image" /> <div class="xs-margin visible-xs"></div> </div> <div class="col-sm-9 col-md-8"> <h1 class="guide-name"> Pharmaceutical Advertising 2025 </h1> <p class="guide-description"> The Pharmaceutical Advertising 2025 guide features over a dozen jurisdictions. The guide covers regulatory frameworks, advertising to the general public and healthcare professionals, transparency, inducement/anti-bribery, enforcement and advertising of veterinary medicines. </p> <p class="writer"> </p> <div class="update-date-container"> <i class="glyphicon glyphicon-info-sign"></i> <p class="-display-inline-block"> <em>Last Updated: March 06, 2025</em> </p> </div> </div> </div> <div class="row country-page-row font-size-18"> <div class="col-md-12"> <div class="sm-margin"></div> <div class="clearfix"> <b> <h3 class="-remove-margin"> <div class="country-tab-container"> <ul class="nav-tabs" id="countryTabs"> <li class="tabLi active"> <a data-ng-click="selectTab('law')" data-toggle="tab" class="tabA"> Law and Practice locations </a> </li> <li class="tabLi"> <a data-ng-click="selectTab('trends')" data-toggle="tab" class="tabA"> Trends and Developments locations </a> </li> <li class="tabLi"> <a data-ng-click="selectTab('compare')" data-toggle="tab" class="tabA"> Compare locations </a> </li> </ul> </div> </h3> </b> </div> <div class="sm-margin"></div> <div class="row"> <div class="col-md-12 col-xs-visible col-sm-visible"> <div class="download-chapter"> <downloads-widget id="962"></downloads-widget> </div> </div> </div> <div> <div class="country-list columns">  <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/belgium"> Belgium </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/canada"> Canada </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/denmark"> Denmark </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/japan"> Japan </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/mexico"> Mexico </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/poland"> Poland </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/portugal"> Portugal </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/spain"> Spain </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/sweden"> Sweden </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/switzerland"> Switzerland </a> </div> <div class="column" data-ng-if="selectedTab == 'law'"> <a href="/practice-guides/pharmaceutical-advertising-2025/usa"> USA </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/china/trends-and-developments"> China </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/denmark/trends-and-developments"> Denmark </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/france/trends-and-developments"> France </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/poland/trends-and-developments"> Poland </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/portugal/trends-and-developments"> Portugal </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/spain/trends-and-developments"> Spain </a> </div> <div class="column" data-ng-if="selectedTab == 'trends'"> <a href="/practice-guides/pharmaceutical-advertising-2025/switzerland/trends-and-developments"> Switzerland </a> </div> </div>  <div class="result-right-box" data-ng-if="selectedTab == 'compare'"> <div> <div class="row"> <h2>Compare law and practice by selecting locations and topic(s)</h2> <div class="col-lg-6"> <h3 class="h3-detail">Select Locations</h3> <div class="inner-addon right-addon"> <i class="glyphicon glyphicon-search"></i> <input type="text" class="form-control search-location" placeholder="Search" data-ng-model="countrySearchTerm" /> </div> <div> <div ng-if="!listOfCountries"> <img src="/Images/loading.gif" /> </div> <div class="location-list"> <div ng-repeat="location in listOfCountries | filter : countrySearchTerm"> <input ng-disabled="SelectedLocation.length >= 5 && !location.checked" type="checkbox" name="checkbox" ng-checked="location.checked" id="child{{location.id}}" value="child{{location.id}}"> <label class="Label ng-scope" ng-click="SetSelectedLocation(location)"> {{location.Description}} </label> <div class="xs-margin"></div> </div> </div> </div> </div> <div class="col-lg-6"> <h3 class="h3-detail">Select Topic(s)</h3> <div class="inner-addon right-addon"> <i class="glyphicon glyphicon-search"></i> <input type="text" class="form-control search-location" placeholder="Search" data-ng-model="topicSearchTerm" /> </div> <div ng-if="!listOfTopics"> <img src="/Images/loading.gif" /> </div> <div class="location-list"> <div ng-repeat="topic in listOfTopics" class="topic-list"> <div> <b>{{topic.Title}}</b> </div> <div class="xs-margin"></div> <div ng-repeat="question in topic.QuestionGroups | filter : topicSearchTerm"> <input type="checkbox" ng-checked="question.checked" name="checkbox" id="{{question.Id}}" value="{{question.Id}}"> <label class="Label ng-scope" ng-click="SetSelectedTopic(question)"> {{question.Description}} </label> <div ng-repeat="questionChild in question.ChildrenQuestionGroups | filter : topicSearchTerm"> <div class="topic-list_wrapper"> <input type="checkbox" ng-checked="questionChild.checked" name="checkbox" id="{{questionChild.Id}}" value="{{questionChild.Id}}"> <label class="Label ng-scope" ng-click="SetSelectedTopic(questionChild);"> {{questionChild.Description}} </label> <div class="xs-margin"></div> </div> </div> </div> </div> </div> </div> </div> <div class="error-msg" ng-if="!selectedLocationLink || !selectedTopicLink"> <div class="msg"> <i class="fa fa-info-circle"></i> <h3>Please select at least one location and one topic to use the compare functionality.</h3> </div> </div> <div class="sm-margin"></div> <div class="row btn-controls clearfix pull-right"> <button class="btn-square-alt" ng-click="reset()" ng-if="selectedLocationLink || selectedTopicLink"> <span>Reset </span> <div class="design-squares"> <div class="design-squares-inside"></div> </div> </button> <a class="btn-main" href="/practice-guides/comparison/962/{{selectedLocationLink}}/{{selectedTopicLink}}" ng-if="selectedLocationLink && selectedTopicLink"> <span>Compare</span> <i class="fa fa-angle-right"></i> <div class="design-squares"> <div class="design-squares-inside"></div> </div> </a> </div> </div> </div> </div> </div> </div> <div class="row country-page-row font-size-18"> <div class="col-md-12 topic-authors col-xs-visible col-sm-visible"> <hr class="bold-seperator" /> <div class="contributor-authors"> <h2 class="authors-title inactive-title"> Author </h2> <div class="author-container"> <a href="/author/details/3650/TGluY29sbiBUc2FuZw" class="author-name-guide-reference"> <div class="author-guide-image-container"> <img src="https://chambersandpartners.azureedge.net/practiceguides/Pictures/505/74981.jpg" class="author-guide-image" onerror="this.src = '/images/empty-picture.png';" /> </div> <b>Lincoln Tsang</b> </a> </div> <br style="clear: both;"> <div class="contributor-company"> <hr class="bold-seperator full-width clear-separator"/> <p> <a href="https://chambers.com/law-firm/ropes-gray-llp-global-2:3650" class="contributor-company-name"><b>Ropes & Gray LLP</b></a> is a pre-eminent global law firm with approximately 1,400 lawyers and legal professionals serving clients in major centres of business, finance, technology and government. The firm has offices in New York, Boston, Washington DC, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul, and has consistently been recognised for its leading practices in many areas, including private equity, M&A, finance, asset management, real estate, tax, antitrust, life sciences, healthcare, intellectual property, litigation and enforcement, privacy and cybersecurity, and business restructuring. Many of the world’s most respected companies and institutions are long-time clients. Ropes & Gray also serves many organisations (and investors and individuals) at all stages of the business life cycle, from start-ups to establishment as industry leaders. It is a thoroughly contemporary firm that can bring 150 years of legal and institutional history to bear on the challenges clients face in today’s global, networked, 24/7 business environment. </p> </div> </div> </div> <div class="col-md-12 topic-introduction"> <hr class="bold-seperator" /> <div> <pgEditorial> <p>Welcome to the 2025 edition of the Chambers Global Practice Guide on Pharmaceutical Advertising. First of all, I would like to express gratitude to colleagues for their expert contributions to this Guide. They have collectively covered the latest developments of a wide range of regulatory compliance issues in their respective jurisdictions. I wish to take the opportunity to make a few opening remarks. </p> <p>January 2025 marked the beginning of the second Trump administration, overseeing the world’s largest national economy and leading global trader. Given the considerable influence of the United States, unsurprisingly, the consequences of the new US administration are beginning to reverberate around the world. Most importantly, there has been significant leadership change of various federal government departments, which will likely result in potentially seismic policy changes, some of which could have profound global impact. </p> <p>Relevant to the life sciences and healthcare sector, the new president nominated Robert Kennedy Jr as the Secretary of State for the Department of Health and Human Services (HHS). Kennedy has been viewed by many as a controversial figure given his stance on vaccines. Many medical experts including a former Food and Drug Administration (FDA) Commissioner have expressed serious concerns about his nomination. Kennedy is also highly critical of direct-to-consumer advertising of prescription medicines – unique to the United States – and has questioned the FDA’s reliance on user fees to support its budget. By a narrow margin, the US Senate voted on 13 February 2025 in favour of installing Kennedy at the helm of the HHS. His remit in government is broad, including overseeing approval of pharmaceuticals, medical devices and biological products such as vaccines through the FDA. Following his confirmation, in his address to HHS staff, Kennedy called for a new era of radical transparency and worked towards tightening up the rules on conflicts of interests on HHS advisory committees to re-establish public trust in the system. The nominated FDA Commissioner, Dr Marty Makary, a practising cancer surgeon at Johns HopkinsUniversity, is yet to be confirmed by the US Senate at the time of writing. He is widely reported to be a system disruptor with a commitment to delivering better evidence-based patient care. </p> <p>Vaccine scepticism and vaccine hesitancy arising from misinformation being disseminated and from misguided views is not a new phenomenon. Vaccine misinformation outpaces efforts to counter it. It has occurred and continues to occur in various geographical regions. Misinformation targets all kinds of vaccines, including childhood vaccines, COVID-19, flu, human papillomavirus and many more. Increasing use of social media has proliferated misinformation internationally that has led to rising levels of vaccine hesitancy. </p> <p>In an era of an increasingly patient-focused and cost-sensitive healthcare delivery environment, patients and those involved in health policy are demanding up-to-date information be communicated to support equitable, inclusive and evidence-based decisions. It is now widely recognised that patients are active partners in their personal healthcare, and their views are increasingly sought in research and regarding effective allocation of healthcare resources. The European Medicines Agency (EMA) in February 2025 highlighted the need for a patient-centred approach to evidence generation to guide regulatory decision-making. </p> <p>Therefore, one cannot overestimate the importance of proper external engagement with healthcare professionals and patients to ensure accurate and up-to-date information is disseminated to advance public health and patient care. Moreover, the sharing of knowledge, information and collaboration with external stakeholders is a powerful tool in science and medical research by translating ideas into innovations. Legitimate scientific communications to convey accurate information can build public trust and stimulate debates on contentious scientific and public health issues. Misinformation erodes scientific integrity. Given their public health impact, such externally facing communications and engagements are increasingly subject to regulatory scrutiny. </p> <p>The laws in many countries distinguish between promotional and non-promotional communications by focusing on the effect of such communications on prescribing behaviours and utilisation. Material or communication that is purely informative, without promotional characteristics, is generally not covered by advertising and promotional rules. However, in certain circumstances, the line between genuine scientific exchange on the one hand and advertising and promotional communications on the other may become blurred. That said, the principles guiding best practice require the communication to be accurate, up to date, verifiable and complete. The communication should also not exaggerate the properties of the product by presenting the information objectively. </p> <p>In October 2023, building on the long-established policy position, the FDA released a non-binding draft guidance on essentially the best practice related to communications with healthcare professionals on off-label use, and this has been considered as representing the most significant development in the FDA’s regulation of off-label communications in recent years. In Europe, the heads of agencies representing all national competent authorities in the EU and EEA and the EMA have considered the need for regulatory authorities and industry to embrace an effective communication strategy to present information that is accurate, meaningful and actionable to a varied audience such as patients, the general public and healthcare professionals to build trust in scientific developments and regulatory systems. </p> <p>The rise of digital advertising and evolving healthcare practices have required companies to adapt to novel regulatory questions that may arise from external engagements. As such, companies need to consider whether internal policies and processes continue to be adequate in the face of emerging compliance risks. The disruptive rise of digital health may lead to certain novel compliance risks. For example, such technologies are often patient-facing software applications which assist patients to treat, prevent or manage illness. Developers should be mindful of the regulatory risks of such applications, given how their products intertwine with the practice of medicine and decision-making with respect to treatment options. The use of social media to promote products has seen a plethora of regulatory actions. It has been widely reported that a growing number of influencers with extensive followings on social media are making claims – regarding a wide array of diseases and conditions – that are not capable of being substantiated. </p> <p>Compliance with the globally diverse regulatory systems will need to be continually adapted to ensure that good practices are applied in proper management of external communications and engagements in response to the ever-changing socio-economic and technological environment. </p> </pgEditorial> </div> </div> </div> </div> <div class="col-md-4 col-md-visible col-lg-visible"> <div class="download-chapter"> <downloads-widget id="962"></downloads-widget> </div> <div class="topic-authors"> <div class="contributor-authors"> <h2 class="authors-title inactive-title"> Author </h2> <div class="author-container"> <a href="/author/details/3650/TGluY29sbiBUc2FuZw" class="author-name-guide-reference"> <div class="author-guide-image-container"> <img src="https://chambersandpartners.azureedge.net/practiceguides/Pictures/505/74981.jpg" class="author-guide-image" onerror="this.src = '/images/empty-picture.png';" /> </div> <b>Lincoln Tsang</b> </a> </div> <br style="clear: both;"> <div class="contributor-company"> <hr class="bold-seperator full-width clear-separator"/> <p> <a href="https://chambers.com/law-firm/ropes-gray-llp-global-2:3650" class="contributor-company-name"><b>Ropes & Gray LLP</b></a> is a pre-eminent global law firm with approximately 1,400 lawyers and legal professionals serving clients in major centres of business, finance, technology and government. The firm has offices in New York, Boston, Washington DC, Chicago, San Francisco, Silicon Valley, London, Hong Kong, Shanghai, Tokyo and Seoul, and has consistently been recognised for its leading practices in many areas, including private equity, M&A, finance, asset management, real estate, tax, antitrust, life sciences, healthcare, intellectual property, litigation and enforcement, privacy and cybersecurity, and business restructuring. Many of the world’s most respected companies and institutions are long-time clients. Ropes & Gray also serves many organisations (and investors and individuals) at all stages of the business life cycle, from start-ups to establishment as industry leaders. It is a thoroughly contemporary firm that can bring 150 years of legal and institutional history to bear on the challenges clients face in today’s global, networked, 24/7 business environment. </p> </div> </div> </div> </div> </div> </div> </section> </div> </div> <div id="footer" class="footer-container"> <div class="container"> <div class="row"> <div class="col-lg-8 footer-left"> <span> © 2025 </span> <span> <span class="footer-copy-big"> Chambers and Partners  |  <a href="https://chambers.com/info/terms-and-conditions" target="_blank">Terms and Conditions</a>  |  <a href="https://chambers.com/info/privacy" target="_blank">Privacy</a> </span> </span> </div> <div class="col-lg-4 footer-right"> <a href="https://www.linkedin.com/company/chambers-and-partners/"> <i class="fa fa-linkedin fa-2x"></i> </a> <a href="https://twitter.com/chambersguides?lang=en"> <i class="fa fa-twitter fa-2x"></i> </a> <a href="https://en-gb.facebook.com/Chambersandpartners/"> <i class="fa fa-facebook fa-2x"></i> </a> </div> <div class="col-lg-12 disclaimer"> <hr /> Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website. </div> </div> </div> </div> </div> <script src="/bundles/jquery?v=FVs3ACwOLIVInrAl5sdzR2jrCDmVOWFbZMY6g6Q0ulE1"></script> <script src="/bundles/bootstrap?v=S9-VFjJll7-h6B6vedKZxuNRBdqXLY3XTPKv3OQRv1w1"></script> <script src="/bundles/pgAngularApp?v=3H8Vldro187bNQn_pFkTw6mgyYDVULmqtnuGtWu9ObE1"></script> <link rel="stylesheet" type="text/css" href="https://guide-downloads-widget.chambers.com/styles.css" /> <script type="text/javascript" async src="https://guide-downloads-widget.chambers.com/download-widget-elements.js"></script> </body> </html>

CINXE.COM

Pharmaceutical Advertising 2025 | Global Practice Guides | Chambers and Partners